Nerve-Sparing radiation aims to protect sexual function in prostate cancer patients
NCT ID NCT03525262
First seen Jun 06, 2026 · Last updated Jun 16, 2026 · Updated 4 times
Summary
This study tests whether a precise type of radiation (SAbR) that avoids the nerves near the prostate can help men with localized prostate cancer keep their ability to have erections. About 124 men will be randomly assigned to standard SAbR or a nerve-sparing version. The goal is to see if the nerve-sparing approach reduces erectile problems without affecting cancer control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Penn Medicine Radiation Oncology
Philadelphia, Pennsylvania, 19104, United States
-
Penrose Hospital
Colorado Springs, Colorado, 80907, United States
-
Stony Brook University Cancer Center
Stony Brook, New York, 11794, United States
-
UCSF ( Department of Radiation Oncology University of California San Francisco)
San Francisco, California, 94143, United States
-
UT Southwestern Cancer Center
Dallas, Texas, 75235, United States
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
University of Michigan- Michigan Medicine
Ann Arbor, Michigan, 48109, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.